Taghrid Asfar1,2, Amanda Perez1, Patrick Shipman1, Adam W Carrico1, David J Lee1,2, Maria Luisa Alcaide3,4, Deborah L Jones5, Judson Brewer6, Tulay Koru-Sengul1,2. 1. Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. 2. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. 3. Division of Infectious Diseases at Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. 4. Internal Medicine, Jackson Memorial Hospital, University of Miami, Miami, FL, USA. 5. Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. 6. Mindfulness Center, Brown University School of Public Health and Warren Alpert School of Medicine, Providence, RI, USA.
Abstract
OBJECTIVE: Approximately one in four deaths among people living with HIV (PLWH) in the United States can be attributed to cigarette smoking. Using a nationally representative sample of PLWH, this study examines the prevalence, time-trends, and correlates of current cigarette smoking among PLWH compared to people without HIV. DESIGN: Secondary analysis of population-based cross-sectional biobehavioral survey. METHODS: Data were pooled from the 1999-2016 National Health and Nutrition Examination Survey (NHANES). All adults (20-59 years) who self-reported their smoking status and were tested for HIV (HIV+ = 152; HIV- = 26 305) were included in the analysis. Prevalence with 95% confidence interval (95% CI), trend analysis by year and group (HIV+/HIV-), and multivariable logistic regression analyses were performed with the complex survey design adjustments. RESULTS: Overall, 47.0% of PLWH were current smokers compared to 25.5% of those without HIV. From 1999 to 2016, the decline in smoking in PLWH was comparable to those without HIV (10.7% vs. 8.0%). PLWH smokers were more likely than PLWH nonsmokers to be substance users (adjusted odds ratio [aOR] = 17.52; 95% CI = 2.04 to 27.8). Compared to smokers without HIV, PLWH smokers were more likely to be older (1.10; 1.06 to 1.14), males (7.96; 2.50 to 25.40), non-Hispanic Black (10.45; 4.13 to 26.45), with depression (Patient Health Questionnaire-9 sum score ≥5) (3.79; 1.22 to 11.79), and less likely to be gay (0.02; 0.00 to 0.07). CONCLUSION: Cigarette smoking among PLWH is a major public health problem in the United States. Targeted and tailored smoking cessation interventions that incorporate assessment and treatment of depression and co-occurring substance use are critical for PLWH, especially among those who are disproportionately affected by smoking and HIV (sexual minority). IMPLICATIONS: This study offers important research implications in four areas:1. The decline in smoking among PLWH over 18 years has been modest, and half of PLWH are still smokers.2. More resources and efforts should be allocated to reduce cigarette smoking among PLWH.3. There is a critical need to develop and test culturally tailored smoking cessation interventions for minority subgroups who are most impacted by HIV infection and smoking (non-Hispanic Blacks and men who have sex with men)4. Smoking cessation interventions designed for PLWH should incorporate assessment and treatment of depression and substance use.
OBJECTIVE: Approximately one in four deaths among people living with HIV (PLWH) in the United States can be attributed to cigarette smoking. Using a nationally representative sample of PLWH, this study examines the prevalence, time-trends, and correlates of current cigarette smoking among PLWH compared to people without HIV. DESIGN: Secondary analysis of population-based cross-sectional biobehavioral survey. METHODS: Data were pooled from the 1999-2016 National Health and Nutrition Examination Survey (NHANES). All adults (20-59 years) who self-reported their smoking status and were tested for HIV (HIV+ = 152; HIV- = 26 305) were included in the analysis. Prevalence with 95% confidence interval (95% CI), trend analysis by year and group (HIV+/HIV-), and multivariable logistic regression analyses were performed with the complex survey design adjustments. RESULTS: Overall, 47.0% of PLWH were current smokers compared to 25.5% of those without HIV. From 1999 to 2016, the decline in smoking in PLWH was comparable to those without HIV (10.7% vs. 8.0%). PLWH smokers were more likely than PLWH nonsmokers to be substance users (adjusted odds ratio [aOR] = 17.52; 95% CI = 2.04 to 27.8). Compared to smokers without HIV, PLWH smokers were more likely to be older (1.10; 1.06 to 1.14), males (7.96; 2.50 to 25.40), non-Hispanic Black (10.45; 4.13 to 26.45), with depression (Patient Health Questionnaire-9 sum score ≥5) (3.79; 1.22 to 11.79), and less likely to be gay (0.02; 0.00 to 0.07). CONCLUSION: Cigarette smoking among PLWH is a major public health problem in the United States. Targeted and tailored smoking cessation interventions that incorporate assessment and treatment of depression and co-occurring substance use are critical for PLWH, especially among those who are disproportionately affected by smoking and HIV (sexual minority). IMPLICATIONS: This study offers important research implications in four areas:1. The decline in smoking among PLWH over 18 years has been modest, and half of PLWH are still smokers.2. More resources and efforts should be allocated to reduce cigarette smoking among PLWH.3. There is a critical need to develop and test culturally tailored smoking cessation interventions for minority subgroups who are most impacted by HIV infection and smoking (non-Hispanic Blacks and men who have sex with men)4. Smoking cessation interventions designed for PLWH should incorporate assessment and treatment of depression and substance use.
Authors: Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read Journal: Am J Public Health Date: 2010-08-19 Impact factor: 9.308
Authors: R L Collins; D E Kanouse; A L Gifford; J W Senterfitt; M A Schuster; D F McCaffrey; M F Shapiro; N S Wenger Journal: Health Psychol Date: 2001-09 Impact factor: 4.267
Authors: S S Munyati; N Redzo; E Dauya; R Matambo; B Makamure; T Bandason; A E Butterworth; L Gwanzura; S Rusakaniko; P R Mason; E L Corbett Journal: Int J Tuberc Lung Dis Date: 2006-11 Impact factor: 2.373
Authors: Amy Lansky; John T Brooks; Elizabeth DiNenno; James Heffelfinger; H Irene Hall; Jonathan Mermin Journal: J Acquir Immune Defic Syndr Date: 2010-12 Impact factor: 3.731
Authors: Renee D Goodwin; Melanie M Wall; Lorra Garey; Michael J Zvolensky; Lisa Dierker; Sandro Galea; Misato Gbedemah; Andrea H Weinberger; Jill M Williams; Mei-Chen Hu; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2017-01-11 Impact factor: 4.492
Authors: Nancy A Hessol; Kathleen M Weber; Gypsyamber D'Souza; Dee Burton; Mary Young; Joel Milam; Lynn Murchison; Monica Gandhi; Mardge H Cohen Journal: Am J Prev Med Date: 2014-04-18 Impact factor: 5.043
Authors: Sarah E Johnson; Enver Holder-Hayes; Greta K Tessman; Brian A King; Tesfa Alexander; Xiaoquan Zhao Journal: Am J Prev Med Date: 2015-10-31 Impact factor: 5.043
Authors: Ahmed Jamal; Israel T Agaku; Erin O'Connor; Brian A King; John B Kenemer; Linda Neff Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Jonathan Shuter; Krishna P Reddy; Emily P Hyle; Cassandra A Stanton; Nancy A Rigotti Journal: Lancet HIV Date: 2021-08-27 Impact factor: 16.070
Authors: Alissa C Kress; Carlen Stadnik; Masauso Moses Phiri; Fastone M Goma; Evelyn Twentyman Journal: Int J Environ Res Public Health Date: 2022-03-24 Impact factor: 3.390
Authors: Taghrid Asfar; Maria Luisa Alcaide; Deborah L Jones; Laura A McClure; Judson Brewer; David J Lee; Adam Carrico Journal: PLoS One Date: 2022-08-25 Impact factor: 3.752